Zibo Meng

1.4k total citations · 1 hit paper
34 papers, 853 citations indexed

About

Zibo Meng is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Zibo Meng has authored 34 papers receiving a total of 853 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 11 papers in Molecular Biology and 8 papers in Surgery. Recurrent topics in Zibo Meng's work include Pancreatic and Hepatic Oncology Research (10 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Protein Degradation and Inhibitors (5 papers). Zibo Meng is often cited by papers focused on Pancreatic and Hepatic Oncology Research (10 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Protein Degradation and Inhibitors (5 papers). Zibo Meng collaborates with scholars based in China, Germany and United States. Zibo Meng's co-authors include Heshui Wu, Jingyuan Zhao, Xin Jin, Shihong Wu, Yongfeng Li, Ping Fan, Zhiqiang Liu, Shanmiao Gou, Dianyun Ren and Zhiqiang Liu and has published in prestigious journals such as Nature Biotechnology, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Zibo Meng

31 papers receiving 838 citations

Hit Papers

Prognostic accuracy of the serum lactate level, the SOFA ... 2019 2026 2021 2023 2019 50 100 150 200

Peers

Zibo Meng
Hee-Jung Wang South Korea
Liang Luo China
Evangelos Messaris United States
Bo Hao China
Patrick Dorn Switzerland
Patrice A. Lee United States
Zibo Meng
Citations per year, relative to Zibo Meng Zibo Meng (= 1×) peers Rossana Franzin

Countries citing papers authored by Zibo Meng

Since Specialization
Citations

This map shows the geographic impact of Zibo Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zibo Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zibo Meng more than expected).

Fields of papers citing papers by Zibo Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zibo Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zibo Meng. The network helps show where Zibo Meng may publish in the future.

Co-authorship network of co-authors of Zibo Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Zibo Meng. A scholar is included among the top collaborators of Zibo Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zibo Meng. Zibo Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Kangning, Jiaming Ding, Lan Fu, et al.. (2025). Degradation-Aware Image Enhancement via Vision-Language Classification. 270–276. 2 indexed citations
2.
Yang, Kangning, et al.. (2025). Survey on Single-Image Reflection Removal Using Deep Learning Techniques. 20–26. 2 indexed citations
3.
Liu, Anqi, Yang Luo, Yingbo Li, et al.. (2025). Separation and detection of ginsenosides: Challenges, industrial implications, and developments. Food Research International. 221(Pt 1). 117069–117069.
4.
Zhang, Rui, Lidan Zhu, Jie Chen, et al.. (2025). Coupled graphene capsule enabling fast and stable lithium storage in micron‐silicon anodes for lithium‐ion batteries. Rare Metals. 44(12). 9833–9849.
5.
Tan, Chin Leng, Katharina A.M. Lindner, Zibo Meng, et al.. (2024). Prediction of tumor-reactive T cell receptors from scRNA-seq data for personalized T cell therapy. Nature Biotechnology. 43(1). 134–142. 26 indexed citations
6.
Sun, Rui, Zibo Meng, Hye-Yoon Lee, Rienk Offringa, & Christof Niehrs. (2023). ROTACs leverage signaling-incompetent R-spondin for targeted protein degradation. Cell chemical biology. 30(7). 739–752.e8. 24 indexed citations
7.
Wang, Yuhang, Mengze Zhou, Ye Tao, et al.. (2022). Discovery of a Series of 5-Amide-1H-pyrazole-3-carboxyl Derivatives as Potent P2Y14R Antagonists with Anti-Inflammatory Characters. Journal of Medicinal Chemistry. 65(23). 15967–15990. 15 indexed citations
8.
Yang, Chong, Shikai Zhu, Hongji Yang, et al.. (2020). FBP1 binds to the bromodomain of BRD4 to inhibit pancreatic cancer progression.. PubMed Central. 10(2). 523–535. 13 indexed citations
9.
Jing, Doudou, Zibo Meng, Binwu Hu, et al.. (2020). FGD1 promotes tumor progression and regulates tumor immune response in osteosarcoma via inhibiting PTEN activity. Theranostics. 10(6). 2859–2871. 42 indexed citations
10.
Meng, Zibo, Jingyuan Zhao, Bo Wang, et al.. (2020). The m6A-Related mRNA Signature Predicts the Prognosis of Pancreatic Cancer Patients. Molecular Therapy — Oncolytics. 17. 460–470. 39 indexed citations
11.
Jin, Can, et al.. (2020). Lymph node ratio predicts prognosis in patients with surgically resected invasive pancreatic cystic neoplasms. Translational Cancer Research. 9(10). 5843–5856. 4 indexed citations
12.
Fan, Ping, Jingyuan Zhao, Zibo Meng, et al.. (2019). Overexpressed histone acetyltransferase 1 regulates cancer immunity by increasing programmed death-ligand 1 expression in pancreatic cancer. Journal of Experimental & Clinical Cancer Research. 38(1). 47–47. 74 indexed citations
13.
Ren, Dianyun, Jingyuan Zhao, Yan Sun, et al.. (2019). Overexpressed ITGA2 promotes malignant tumor aggression by up-regulating PD-L1 expression through the activation of the STAT3 signaling pathway. Journal of Experimental & Clinical Cancer Research. 38(1). 485–485. 78 indexed citations
14.
Zhao, Jingyuan, Zibo Meng, Chao Xie, et al.. (2019). B7-H3 is regulated by BRD4 and promotes TLR4 expression in pancreatic ductal adenocarcinoma. The International Journal of Biochemistry & Cell Biology. 108. 84–91. 26 indexed citations
15.
Meng, Zibo, et al.. (2019). Tumor location as an indicator of survival in T1 resectable pancreatic ductal adenocarcinoma: a propensity score-matched analysis. BMC Gastroenterology. 19(1). 59–59. 20 indexed citations
16.
Zhang, Zhenguo, Kun Hao, Hanwen Li, et al.. (2019). Design, synthesis and anti-inflammatory evaluation of 3-amide benzoic acid derivatives as novel P2Y14 receptor antagonists. European Journal of Medicinal Chemistry. 181. 111564–111564. 24 indexed citations
17.
Sun, Na, et al.. (2019). Pulmonary papillary squamous cell carcinoma: a population-based analysis of incidence, treatment, and prognosis. Journal of Thoracic Disease. 11(10). 4271–4281. 1 indexed citations
18.
Fan, Ping, Bo Wang, Zibo Meng, Jingyuan Zhao, & Xin Jin. (2018). PES1 is transcriptionally regulated by BRD4 and promotes cell proliferation and glycolysis in hepatocellular carcinoma. The International Journal of Biochemistry & Cell Biology. 104. 1–8. 32 indexed citations
19.
Meng, Zibo, et al.. (2018). Prognostic value of progesterone receptor in solid pseudopapillary neoplasm of the pancreas: evaluation of a pooled case series. BMC Gastroenterology. 18(1). 187–187. 7 indexed citations
20.
Zhang, Yushun, Feng Guo, Zibo Meng, et al.. (2017). Decreased high density lipoprotein cholesterol is an independent predictor for persistent organ failure, pancreatic necrosis and mortality in acute pancreatitis. Scientific Reports. 7(1). 8064–8064. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026